Mdxwealth

mdxhealth is a commercial-stage precision diagnostics company specializing in molecular diagnostic tests for urologic cancers. Its flagship products include non-invasive urine and tissue-based assays that use proprietary genetic and epigenetic biomarkers to improve the diagnosis and management of prostate cancer. The company also offers tests for predicting therapeutic response in glioblastoma and identifying effective antibiotics in urinary tract infections. mdxhealth’s clinical results have established its products as valuable tools to personalize patient care by reducing unnecessary procedures and improving treatment selection.